Last update :
07/04/2025
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Cardiotonic   Digoxin  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Cardixin Egypt
Celoxin India
Digibind New Zealand, United States of America
Digocard Argentina, Ecuador
Digosin Japan
Digoxin Argentina, Canada, Denmark, Ecuador, Finland, Great Britain, Hungary, Iran, Poland, Sweden, United States of America
Digoxina Argentina, Ecuador, Mexico, Spain, Venezuela
Digoxine France, Greece, Switzerland
Geoxin India
Lanibos Saudi Arabia
Lanicor Germany
Lanoxin Belgium, Chile, Egypt, Great Britain, Iran, Ireland, Italy, Luxembourg, Malaysia, Netherlands, New Zealand, Norway, Portugal, Saudi Arabia, United Arab Emirates, United States of America
Loxinan Mexico
Stability in solutions   injection   Stability in solutions : Digoxin     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 2,5 µg/ml 23-26°C Light
48 Hour
618
Biological analysis
Glass NaCl 0,9% or Glucose 5% 2,5 µg/ml 4°C Protect from light
48 Hour
618
Biological analysis
Glass Sodium chloride 0,9% 50 µg/ml 23-27°C Light
180 Day
4690
Level of evidence B+
Glass Sodium chloride 0,9% 50 µg/ml 3-7°C Light
180 Day
4690
Level of evidence B+
Glass Ringer’s lactate solution 2,5 µg/ml 23°C-26°C Light
6 Hour
618
Biological analysis
  Mentions Légales